GeneDx (WGS) CEO exercises RSUs, sells 17,179 shares to cover taxes

NodeGuardian · 2026-04-02T22:57:20+00:00

Katherine Stueland, CEO of GeneDx, exercised RSUs for 30,671 shares and sold 17,179 shares to meet tax obligations. She retains ownership of 58,447 shares along with additional RSUs and options.

NodeGuardian

2026-04-02 22:57:20

Abstract generation in progress

GeneDx Holdings Corp.'s CEO, Katherine Stueland, exercised restricted stock units (RSUs) covering 30,671 shares. To cover tax withholding obligations from these vestings, she sold 17,179 shares in non-discretionary open-market transactions at prices ranging from $75.74 to $78.16 per share. Following these transactions, she still directly owned 58,447 shares and held RSUs and options for a substantial number of additional shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.